Ex vivo expansion of CD4(+)CD25(+) T regulatory cells for immunosuppressive therapy (Q37294572)

19 August 2017

1 reference

title

Ex vivo expansion of CD4(+)CD25(+) T regulatory cells for immunosuppressive therapy (English)

1 reference

19 August 2017

1

Piotr Trzonkowski

1 reference

19 August 2017

Magdalena Szaryńska

2

1 reference

PubMed ID

18855921

19 August 2017

Jolanta Myśliwska

series ordinal

3

1 reference

PubMed ID

18855921

19 August 2017

Andrzej Myśliwski

series ordinal

4

1 reference

19 August 2017

1 March 2009

1 reference

19 August 2017

1 reference

19 August 2017

75

1 reference

19 August 2017

3

1 reference

19 August 2017

175-188

1 reference

Immunosuppressor T cells in tumor bearing host

19 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Lipopolysaccharide-activated CD4+CD25+ T regulatory cells inhibit neutrophil function and promote their apoptosis and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Human CD4+CD25+ regulatory T cells share equally complex and comparable repertoires with CD4+CD25- counterparts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

CD27/CFSE-based ex vivo selection of highly suppressive alloantigen-specific human regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Differential expression of Smad7 transcripts identifies the CD4+CD45RChigh regulatory T cells that mediate type V collagen-induced tolerance to lung allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Homeostatic repopulation by CD28-CD8+ T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

A novel costimulation pathway via the 4C8 antigen for the induction of CD4+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

IL-2, regulatory T cells, and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-{beta}.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Antigen-specific T cell repertoire modification of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Elevated T regulatory cells in long-term stable transplant tolerance in rhesus macaques induced by anti-CD3 immunotoxin and deoxyspergualin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Expression of activated Notch3 in transgenic mice enhances generation of T regulatory cells and protects against experimental autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Human CD4+CD25+ Regulatory T Lymphocytes Inhibit Lipopolysaccharide-Induced Monocyte Survival through a Fas/Fas Ligand-Dependent Mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

Regulatory T cells in transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

IMMUNOGENETIC CONSEQUENCES OF VASCULAR ANASTOMOSES BETWEEN BOVINE TWINS

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Actively acquired tolerance of foreign cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Human T regulatory cells can use the perforin pathway to cause autologous target cell death

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

In vitro expanded human CD4+CD25+ regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Regulatory T cells in transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Nonself-antigens are the cognate specificities of Foxp3+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Oral administration of myelin induces antigen-specific TGF-beta 1 secreting T cells in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

CD4+CD25high regulatory cells in human peripheral blood

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Ex vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25(high) T cells for immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Isolation of CD4+CD25+ regulatory T cells for clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Regulatory T-cell physiology and application to treat autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Differences in kinetics of donor lymphoid cells in response to G-CSF administration may affect the incidence and severity of acute GvHD in respective HLA-identical sibling recipients.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

A peripheral circulating compartment of natural naive CD4 Tregs

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

CD4+CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Reversal of airway hyperresponsiveness by induction of airway mucosal CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

CD18 is required for optimal development and function of CD4+CD25+ T regulatory cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Activated CD4+CD25+ T cells selectively kill B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

IL-2Rbeta links IL-2R signaling with Foxp3 expression

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

CD154 on the surface of CD4+CD25+ regulatory t cells contributes to skin transplant tolerance

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

A link between PDL1 and T regulatory cells in fetomaternal tolerance

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Neuropilin-1: a surface marker of regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Calcitriol started in the donor, expands the population of CD4+CD25+ T cells in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Everolimus and basiliximab permit suppression by human CD4+CD25+ cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Following anti-CD25 treatment, a functional CD4+CD25+ regulatory T-cell pool is present in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

CD52 is a novel costimulatory molecule for induction of CD4+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

TNF downmodulates the function of human CD4+CD25hi T-regulatory cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

The main function of IL-2 is to promote the development of T regulatory cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Cutting edge: self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Large-scale expansion of rat CD4+ CD25+ T(reg) cells in the absence of T-cell receptor stimulation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Agonistic anti-4-1BB antibody promotes the expansion of natural regulatory T cells while maintaining Foxp3 expression

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

A phase I study of ultra low dose interleukin-2 and stem cell factor in patients with HIV infection or HIV and cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Telomere length of in vivo expanded CD4(+)CD25 (+) regulatory T-cells is preserved in cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+CD25+ T cell regulatory functions

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Flow cytometry-based methods for studying signaling in human CD4+CD25+FOXP3+ T regulatory cells.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Inducing and expanding regulatory T cell populations by foreign antigen

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

DNA methylation controls Foxp3 gene expression

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Epigenetic control of the foxp3 locus in regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Transforming growth factor beta induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Tr1 cells: from discovery to their clinical application.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Indoleamine 2,3-dioxygenase and tumor-induced tolerance

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Antigen-induced regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Hepatoma cells inhibit the differentiation and maturation of dendritic cells and increase the production of regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

The functional immaturity of dendritic cells can be relevant to increased tolerance associated with cord blood transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Tolerogenic dendritic cells and the quest for transplant tolerance

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Human plasmacytoid dendritic cells from patients with chronic hepatitis B virus infection induce the generation of a higher proportion of CD4(+) and CD25(+) regulatory T cells compared with healthy patients.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Superiority of bone marrow-derived dendritic cells over monocyte-derived ones for the expansion of regulatory T cells in the macaque

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Human CD4+CD25high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Generation and expansion of human CD4+ CD25+ regulatory T cells with indirect allospecificity: Potential reagents to promote donor-specific transplantation tolerance

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

In vitro expanded alloantigen-specific CD4+CD25+ regulatory T cell treatment for the induction of donor-specific transplantation tolerance

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

"Infectious" transplantation tolerance.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-beta

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Notch1 and TGFbeta1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

IL-10 and TGF-beta induce alloreactive CD4+CD25- T cells to acquire regulatory cell function

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Superantigen-Induced Regulatory T Cells Display Different Suppressive Functions in the Presence or Absence of Natural CD4+CD25+ Regulatory T Cells In Vivo

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Combined treatment with triptolide and rapamycin prolongs graft survival in a mouse model of cardiac transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Special regulatory T cell review: The suppression problem!

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

London's disastrous drug trial has serious side effects for research

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Clinical application of expanded CD4+25+ cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20659

7 January 2021

Identifiers

DOI

10.1002/CYTO.A.20659

1 reference

19 August 2017

1 reference

PubMed ID

18855921